Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

A study by the Evernorth Research Institute looking at national prescription drug use trends found GLP-1 use between 2023-2024 rose 84.6% in Gen Alpha (ages 14 and younger). The age group was ...

After decades of increases, diabetes-related health care costs have plateaued, according to a new Trends in Spend report from Nomi Health.

Related Massive study looks at benefits, risks of GLP-1 weight-loss drugs GLP-1 medications show promise in slowing ... GLP-1 drug use rose from 0.1% of the population in 2018 to 0.4% in 2022.

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

As a result, estimated annual spending on GLP-1 drugs among non-diabetics rose from $1.6 billion between 2018 and 2021 to $5.8 billion in 2022, the study showed.

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...